PPARA and inflammatory bowel disease: While no genetic mutations in MG53 or PPARα has been implicated in the pathogenesis of IBD, impaired PPARα signaling has been linked to the pathogenesis of colitis23 as well as AOM or AOM/DSS-induced colon carcinogenesis36.